363 related articles for article (PubMed ID: 28002569)
1. Protective Role of ICOS and ICOS Ligand in Corneal Transplantation and in Maintenance of Immune Privilege.
Kunishige T; Taniguchi H; Terada M; Akiba H; Yagita H; Abe R; Hori J
Invest Ophthalmol Vis Sci; 2016 Dec; 57(15):6815-6823. PubMed ID: 28002569
[TBL] [Abstract][Full Text] [Related]
2. VISTA Is Crucial for Corneal Allograft Survival and Maintenance of Immune Privilege.
Kunishige T; Taniguchi H; Ohno T; Azuma M; Hori J
Invest Ophthalmol Vis Sci; 2019 Dec; 60(15):4958-4965. PubMed ID: 31790558
[TBL] [Abstract][Full Text] [Related]
3. Epithelium-deficient corneal allografts display immune privilege beneath the kidney capsule.
Hori J; Joyce N; Streilein JW
Invest Ophthalmol Vis Sci; 2000 Feb; 41(2):443-52. PubMed ID: 10670474
[TBL] [Abstract][Full Text] [Related]
4. Blockade of the 4-1BB (CD137)/4-1BBL and/or CD28/CD80/CD86 costimulatory pathways promotes corneal allograft survival in mice.
Asai T; Choi BK; Kwon PM; Kim WY; Kim JD; Vinay DS; Gebhardt BM; Kwon BS
Immunology; 2007 Jul; 121(3):349-58. PubMed ID: 17376197
[TBL] [Abstract][Full Text] [Related]
5. Role of CD4+ T cells in immunobiology of orthotopic corneal transplants in mice.
Yamada J; Kurimoto I; Streilein JW
Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2614-21. PubMed ID: 10509657
[TBL] [Abstract][Full Text] [Related]
6. GITR ligand-mediated local expansion of regulatory T cells and immune privilege of corneal allografts.
Hori J; Taniguchi H; Wang M; Oshima M; Azuma M
Invest Ophthalmol Vis Sci; 2010 Dec; 51(12):6556-65. PubMed ID: 20702832
[TBL] [Abstract][Full Text] [Related]
7. B7-H1-induced apoptosis as a mechanism of immune privilege of corneal allografts.
Hori J; Wang M; Miyashita M; Tanemoto K; Takahashi H; Takemori T; Okumura K; Yagita H; Azuma M
J Immunol; 2006 Nov; 177(9):5928-35. PubMed ID: 17056517
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous blockade of co-stimulatory signals, CD28 and ICOS, induced a stable tolerance in rat heart transplantation.
Guo L; Fujino M; Kimura H; Funeshima N; Kitazawa Y; Harihara Y; Tezuka K; Makuuchi M; Suzuki S; Li XK
Transpl Immunol; 2003; 12(1):41-8. PubMed ID: 14551031
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of costimulatory pathway modulation on corneal allograft survival.
Watson MP; George AJ; Larkin DF
Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3417-22. PubMed ID: 16877411
[TBL] [Abstract][Full Text] [Related]
10. A novel alloantigen-specific CD8+PD1+ regulatory T cell induced by ICOS-B7h blockade in vivo.
Izawa A; Yamaura K; Albin MJ; Jurewicz M; Tanaka K; Clarkson MR; Ueno T; Habicht A; Freeman GJ; Yagita H; Abdi R; Pearson T; Greiner DL; Sayegh MH; Najafian N
J Immunol; 2007 Jul; 179(2):786-96. PubMed ID: 17617568
[TBL] [Abstract][Full Text] [Related]
11. Endogenous Toll-like Receptor 2 Modulates Th1/Treg-Promoting Dendritic Cells in Mice Corneal Transplantation Model.
Su YR; Chen MT; Xiong K; Bai L
Curr Eye Res; 2020 Jul; 45(7):774-781. PubMed ID: 31842628
[TBL] [Abstract][Full Text] [Related]
12. Targeting of inducible costimulator (ICOS) expressed on alloreactive T cells down-regulates graft-versus-host disease (GVHD) and facilitates engraftment of allogeneic bone marrow (BM).
Taylor PA; Panoskaltsis-Mortari A; Freeman GJ; Sharpe AH; Noelle RJ; Rudensky AY; Mak TW; Serody JS; Blazar BR
Blood; 2005 Apr; 105(8):3372-80. PubMed ID: 15618467
[TBL] [Abstract][Full Text] [Related]
13. Augmented ICOS expression in patients with early diffuse cutaneous systemic sclerosis.
Hasegawa M; Fujimoto M; Matsushita T; Hamaguchi Y; Takehara K
Rheumatology (Oxford); 2013 Feb; 52(2):242-51. PubMed ID: 23024058
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of ICOS ligand by interaction with ICOS functions as a regulatory mechanism for immune responses.
Watanabe M; Takagi Y; Kotani M; Hara Y; Inamine A; Hayashi K; Ogawa S; Takeda K; Tanabe K; Abe R
J Immunol; 2008 Apr; 180(8):5222-34. PubMed ID: 18390703
[TBL] [Abstract][Full Text] [Related]
15. Induction of anterior chamber-associated immune deviation by corneal allografts placed in the anterior chamber.
Yamada J; Streilein JW
Invest Ophthalmol Vis Sci; 1997 Dec; 38(13):2833-43. PubMed ID: 9418737
[TBL] [Abstract][Full Text] [Related]
16. Blockade of costimulatory CD27/CD70 pathway promotes corneal allograft survival.
Narimatsu A; Hattori T; Usui Y; Ueno H; Funaki T; Komatsu H; Nakagawa H; Akiba H; Goto H
Exp Eye Res; 2020 Oct; 199():108190. PubMed ID: 32798537
[TBL] [Abstract][Full Text] [Related]
17. T cell subsets in the immune rejection of murine heterotopic corneal allografts.
Matoba AY; Peeler JS; Niederkorn JY
Invest Ophthalmol Vis Sci; 1986 Aug; 27(8):1244-54. PubMed ID: 2942516
[TBL] [Abstract][Full Text] [Related]
18. ACAID induced by allogeneic corneal tissue promotes subsequent survival of orthotopic corneal grafts.
Sonoda A; Sonoda Y; Muramatu R; Streilein JW; Usui M
Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):790-8. PubMed ID: 10711695
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-1 receptor antagonist therapy and induction of anterior chamber-associated immune deviation-type tolerance after corneal transplantation.
Yamada J; Zhu SN; Streilein JW; Dana MR
Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4203-8. PubMed ID: 11095616
[TBL] [Abstract][Full Text] [Related]
20. Role of tumor necrosis factor receptor expression in anterior chamber-associated immune deviation (ACAID) and corneal allograft survival.
Niederkorn JY; Mayhew E; Mellon J; Hegde S
Invest Ophthalmol Vis Sci; 2004 Aug; 45(8):2674-81. PubMed ID: 15277491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
